Thursday, November 02, 2006

Investing in Adult Stem Cell Research

A CNN Money article from August talked about how biotech companies working with adult stem cells are getting closer to producing treatments. The article mentions three companies in particular:
  1. ASTM (Aastrom Biosciences, Inc.) -- working on treatment to regrow bone tissue
  2. OSIR (Osiris Therapeutics) -- IPO'd on Aug 4. Just began Phase 3 trials for Prochymal for treatment of Acute Graft vs. Host disease, and Phase 2 trials (also Prochymal) for Crohn's disease.
  3. CYTX (Cytori Therapeutics, Inc.) -- working on using patient's adipose tissue for breast reconstruction


Post a Comment

<< Home